SBI US Specific Equity Active FoF - Regular Plan - Growth
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth
Chart Comparison
Overview
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Fund | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Average | Very High |
| Asset Size (Cr) | ₹1061 Cr | ₹3598 Cr |
| Min Investment | ₹5000 | ₹100 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹100 |
| Launch Date | 22 Mar 2021 | 05 Mar 2020 |
| Category | International | International |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE 500 | Russel 1000 Equal Weighted Technology |
| Turn Over | 37% | 18% |
| Expense Ratio | 1.6 | 2.35 |
| Manager | Pradeep Kesavan | Bhavesh Jain |
| ISIN Code | INF200KA1T96 | INF754K01LC5 |
| Exits Load | SBI International Access - US Equity FOF - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Edelweiss US Technology Equity FOF - Growth charges 1.0% of sell value; if fund sold before 90 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 1 Month | 2.58% | 1.43% |
| 6 Month | 32.72% | 42.6% |
| 1 Year | 22.07% | 38.1% |
| 3 Year | 24.92% | 38.08% |
| 5 Year | - | 17.52% |
SIP Return Analysis
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 6 Month | 10.12% | 11.46% |
| 1 Year | 35.36% | 39% |
| 3 Year | 26.16% | 34.64% |
| 5 Year | - | 23% |
Rolling Lumpsum Returns
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| 1 Year | 14.25% | 29.08% |
| 3 Year | 12.97% | 9.54% |
| 5 Year | - | 17.6% |
Risk Management
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Standard Deviation | 15.17% | 24.74% |
| Sharp | 1.23% | 1.13% |
| Beta | 1.06% | - |
| Alpha | -2.29% | - |
Fund Managers
| Scheme Name | SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Name | Pradeep Kesavan | Bhavesh Jain |
| Total AUM | ₹434274 Cr | ₹0 Cr |
| Funds Managed | 43 | 22 |
| SBI US Specific Equity Active FoF - Regular Plan - Growth | Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
Market Cap
| Scheme Name |
SBI US Specific Equity Active FoF - Regular Plan - Growth |
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Others | 100 | 100 |
Sector Allocation
| Scheme Name |
SBI US Specific Equity Active FoF - Regular Plan - Growth |
Edelweiss US Technology Equity Fund of Fund- Regular Plan- Growth |
|---|---|---|
| Others | 100 | 100 |
Top Comparisons
Nippon India Pharma Fund-Growth Plan-Growth Option
3Y Returns21.85%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
3Y Returns22.69%
HDFC Multi-Asset Active FOF - Growth
3Y Returns16.89%
HSBC Multi Asset Active FOF - Growth
3Y Returns15.66%
DSP Flexi Cap Fund - Regular Plan - Growth
3Y Returns18.06%
Axis Flexi Cap Fund - Regular Plan - Growth
3Y Returns14.87%
BANDHAN Arbitrage Fund - Regular Plan - Growth
3Y Returns6.97%
Mirae Asset Arbitrage Fund Regular Growth
3Y Returns6.86%